Browse our comprehensive collection of market intelligence reports.
Continuous glucose monitoring systems in the Middle East and Africa are positioned within a healthcare environment where diabetes prevalence, late diagnosis rates, and uneven access to endocrinology care shape procurement behavior. Demand is concentrated among insulin-dependent patients and hospital systems managing acute glycemic variability in intensive and post-operative settings. Purchasing decisions are driven less by consumer preference and more by clinical outcomes, reimbursement cover
Demand for continuous glucose monitoring in Israel is anchored in structured diabetes care pathways and reimbursement coverage for clinically defined patient groups, particularly type 1 diabetes and high-risk pregnancies. National health system provisions support device access under defined clinical conditions, shaping a market that is procurement-driven rather than discretionary. Coverage frameworks and specialist-led prescription models have made CGM a standard tool in intensive diabetes ma
Lactobionic acid is a polyhydroxy acid (PHA) produced through the oxidation of lactose, combining exfoliating, humectant, antioxidant, and metal-chelating properties within a single ingredient. Commercial demand extends across cosmetics, pharmaceutical formulations, medical preservation solutions, food applications, and specialty chemical products.
Dioctyl maleate (DOM) is a specialty ester produced through the esterification of maleic acid with 2-ethylhexanol. It functions primarily as a reactive intermediate, plasticizer, surfactant component, and modifier in adhesives, inks, coatings, and specialty polymer formulations. Commercial demand depends less on standalone consumption and more on activity across downstream industries including construction chemicals, industrial coatings, textiles, and specialty chemical manufacturing.
Continuous glucose monitoring (CGM) has become an established component of diabetes management across North America as healthcare providers place greater emphasis on real-time glucose data, improved glycemic control, and reduced dependence on routine fingerstick testing. The market encompasses wearable sensors, transmitters, receivers, smartphone-based monitoring platforms, software analytics, and connected diabetes management ecosystems supplied through hospitals, specialty clinics, pharmaci
Clinical laboratories are placing greater emphasis on coagulation testing as healthcare systems expand screening and monitoring for bleeding disorders, thrombotic diseases, cardiovascular conditions, liver disease, and anticoagulant therapy. Coagulation analyzers have evolved from standalone laboratory instruments into integrated diagnostic platforms that support routine and specialized hemostasis testing with higher throughput, improved analytical consistency, and automated quality managemen
Continuous glucose monitoring (CGM) systems have become an increasingly important component of diabetes management in Canada as healthcare providers place greater emphasis on preventive care, glycemic control, and long-term reduction of diabetes-related complications. Unlike conventional blood glucose monitoring methods that require intermittent finger-prick testing, CGM devices provide continuous measurement of interstitial glucose levels, allowing patients and clinicians to identify glucose
Photopolymerization process 3D printing represents one of the most mature categories within additive manufacturing, offering high dimensional accuracy, smooth surface finishes, and the capability to manufacture geometrically complex components with minimal tooling. The market primarily comprises stereolithography (SLA), digital light processing (DLP), and continuous digital light processing (CDLP) technologies, each addressing different production requirements ranging from rapid prototyping t
Neuroprosthetics combines implantable or external electronic systems with the nervous system to restore, modulate, or improve neurological function that has been impaired by disease, injury, or congenital disorders. Commercial applications span hearing restoration, movement disorders, epilepsy management, chronic pain therapy, bladder dysfunction, vision restoration, and emerging brain-computer interface (BCI) technologies. Demand is concentrated in healthcare systems capable of supporting mu
Hexane is an aliphatic hydrocarbon solvent primarily obtained during crude oil refining and natural gas processing. Commercial demand is concentrated in three application groups: edible oil extraction, industrial solvents, and cleaning and degreasing operations. Purchasing decisions are largely influenced by solvent purity, evaporation characteristics, extraction efficiency, regulatory compliance, and supply reliability rather than price alone. Food-grade and polymer-grade products command st
The Application-Specific Integrated Circuits (ASICs) market is experiencing strong growth due to the transformation of digital infrastructure. Other factors leading to the market are rising computational demands and the increasing need for efficiency and specialisation across industries. Finance, telecommunications, artificial intelligence, and consumer electronics are becoming more data-intensive, and ASICS are gaining popularity. The advantages of ASICs are that they offer speed, perf
Japan’s continuous glucose monitoring (CGM) market is shaped by structured diabetes management pathways, high clinical screening rates, and a strong preference for technology-supported chronic disease monitoring. Demand is anchored in insulin-dependent diabetes care, where frequent glucose variability requires near real-time tracking rather than episodic testing. Hospitals, specialist clinics, and home care settings operate as interconnected channels, with prescribing decisions often guided b